Document is current

Article History

Received: 4 October 2025

Accepted: 9 October 2025

First Online: 30 October 2025

Conflict of interest

: C. Matuschek has received research funding from the Stiftung Deutsche Krebshilfe outside the submitted work. K. Borm has received speaker honoraria from Accuray and a travel grant from Carl Zeiss. Outside the submitted work, J. Hörner-Rieber received speaker fees from ViewRay Inc., Pfizer Inc., Accuray Sarl, Sanofi, and Astra Zeneca, as well as travel reimbursement from Varian Medical Systems and research grants from IntraOP Medical and Varian Medical Systems. R. Fietkau received grants/contracts from AstraZeneca, Novocure, MSD, and Siemens as well as honoraria from Merck serono, AstraZeneca, MSD, Novocure, and Siemens; he also received support for attending meetings from Promedicis, MSD, AstraZeneca, Siemens, Novocure, and Bristol Myers Squibb and took part in the data safety monitoring board/advisory board of MSD, AstraZeneca, and Novocure. D. Krug has received honoraria from AstraZeneca, best practice onkologie, ESO, ESMO, Gilead, med update, Merck Sharp & Dohme, Novartis, onkowissen, PINK gegen Brustkrebs GmbH, and Pfizer as well as research funding from the Stiftung Deutsche Krebshilfe and Merck KGaA. Outside the submitted work, K. Dellas has received research funding from the Stiftung Deutsche Krebshilfe and honoraria from Merck Healthcare KGaA and Roche Pharma AG. N.M. Duma, J. Dunst, T. Hehr, M. Pazos, V. Strnad, W. Budach, and M.D. Piroth declare that they have no competing interests.